<DOC>
	<DOC>NCT00383188</DOC>
	<brief_summary>Investigating the safety and tolerability of a p38 inhibitor as monotherapy in subjects who have failed at least 1 DMARD.</brief_summary>
	<brief_title>An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<criteria>Diagnosed with RA and has failed at least 1 DMARD therapy Any other inflammatory arthritis and any significant history of acute or chronic infection with immunomodulatory etiology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Arthritis, Rheumatoid</keyword>
</DOC>